These new breakthroughs lay an important foundation for future researches on the mechanism of METTL1–WDR4‐mediated m7G‐tRNA modification in cancer occurrence and provide new ideas to design and develop METTL1–WDR4 methyltransferase inhibitors as potential novel anticancer medications. The gene discussed is METTL1; the disease is cancer.